Pharmafile Logo
Pharmafocus logo
Advanced Search

BMS partners again with the company behind Opdivo

December 14, 2017
Medical Communications, Sales and Marketing Bristol-Myers Squibb, biotech, drugs, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has once again struck a deal with Ono Pharmaceutical for multiple programs, seeking to discover a boost to …

News
shutterstock_138095450

Novartis, Abbott targeted by Indian watchdog over allegations of price collusion

December 14, 2017
Sales and Marketing Abbott, Emcure Pharma, Galdus, Novartis, USV, diabetes, pharma, vildagliptin

Novartis, Abbott, Emcure Pharma and USV have become the targets of an investigation by the Competition Commission of India (CCI) …

News
fullsizerender_2_rav

Working Life: Dr Rav Seeruthun, Medical Director of Roche UK

December 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …

Feature
bacteria-1777339_960_720

FDA launches new method for antibiotic prescription

December 14, 2017
Medical Communications antibiotic resistance, biotech, drugs, pharma, pharmaceutical

The fight against the growth of antibiotic resistance has become a major talking point internationally in recent years and the …

News
blood-75301_640

‘Mind-blowing’ gene therapy could herald a cure for haemophilia, study shows

December 14, 2017
Research and Development haemophilia, pharma

A team of clinical researchers at Barts Health NHS Trust and Queen Mary University of London have reported that a …

News

What will Pfizer do with its second Remicade biosimilar?

December 14, 2017
Sales and Marketing Ixifi, Johnson & Johnson, Pfizer, Remicade, biosimilars, biotech, drugs, inflectra, pharma, pharmaceutical

Pfizer is now in the unusual position of owning two biosimilars to Johnson & Johnson’s Remicade, though one of these …

News
daiichi-sankyo-us

Daiichi Sankyo: Two steps forward, one step back in cancer deals

December 14, 2017
Sales and Marketing Daiichi Sankyo, biotech, drugs, pharma, pharmaceutical

Daiichi Sankyo had a busy day in terms of its deals in oncology, not only did it tear up its …

News
mundipharma_4_204_of_291

Mundipharma names new President and CEO

December 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, Napp, Napp Pharmaceuticals, appointment

Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as …

Appointment

Sanofi sees pipeline fruition in 2018

December 13, 2017
Research and Development Sanofi, biotech, drugs, pharma, pharmaceutical

In news that Sanofi will no doubt be hoping should divert attention away from the Dengvaxia scandal, the company revealed …

News
shutterstock_159488225

Blood cancer patients over 75 are significantly underrepresented in clinical trials, study finds

December 13, 2017
Research and Development FDA, blood cancer, leukaemia, lymphoma, myeloid leukaemia, pharma

The FDA’s first comprehensive analysis of clinical trial enrolment in older patients with blood cancers has revealed that the population …

News
cocoa-174872_960_720

FDA cracks down on snortable chocolate powder

December 13, 2017
Medical Communications, Research and Development FDA, biotech, drugs, pharma, pharmaceutical

The FDA has taken action on Coco Loko and Legal Lean Syrup, both made by Arco Globus Trading LLC, after …

News

J&J’s Darzalex cuts risk of disease progression and death by 50%, new study shows

December 13, 2017
Research and Development Genmab, J&J, JJ, Janssen, Johnson & Johnson, darzalex, multiple myeloma, pharma

Johnson and Johnson has revealed data which demonstrates that Darzalex (daratumumab), when combined with a regimen of bortezomib, melphalan and …

News
teva_canada

Tumultuous times at Teva continue, with Chairman exit

December 13, 2017
Medical Communications, Research and Development Teva, biotech, drugs, pharma, pharmaceutical

In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …

News
fdaoutsideweb

FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017
Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …

News
money-2180330_960_720

Latest US company accused of price gouging, after 2,469% increase

December 12, 2017
Manufacturing and Production, Sales and Marketing Avondale Pharmaceutical, Niacor, biotech, drugs, pharma, pharmaceutical

It seems that no matter how much bad press comes their way, certain pharmaceutical companies are more than happy to …

News
shutterstock_212035546

Single, high-dose vaccine could provide better protection against cholera outbreaks, new research shows

December 12, 2017
Manufacturing and Production, Research and Development Africa, Asia, Caribbean, Cholera, Vaccine, paxvax, pharma

A team of researchers at the University of Maryland School of Medicine (UMSOM) has been assessing the effectiveness of a …

News
sanofi_new_paris_hq

Sanofi issues US-wide recall for arthritis product, after adverse events

December 12, 2017
Manufacturing and Production Sanofi, Synvisc-One, biotech, drugs, pharma, pharmaceutical

Sanofi has announced a recall of 12,380 syringes of its Synvisc-One product for the treatment of osteoarthritis, after it was …

News
brainss

Ionis scores huge breakthrough in Huntington’s, Roche licenses drug

December 12, 2017
Manufacturing and Production, Research and Development Ionis, Roche, biotech, drugs, pharma, pharmaceutical

Ionis Pharmaceuticals has revealed findings from its Phase 1/2a study into a treatment for Huntington’s disease and the strong data …

News

Exscientia appoints Oxford Innovation Sciences founder and ex-Lansdowne CEO as Deputy Chairman

December 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Snow, Exscientia, appointment

Exscientia, an Oxford-based drug design firm which has made headlines this year for its collaboration with GlaxoSmithKline to leverage its …

Appointment
hands-600497_960_720

To succeed in emerging market medicine, anticipation and innovation are essential

December 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …

Feature
The Gateway to Local Adoption Series

Latest content

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026

eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer

March 6, 2026